Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate versus delayed insertion of intrauterine contraception at the time of medical abortion
2024-517082-16-01Phase 3Authorised
- Sponsor
- Karolinska Institutet
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of avatrombopag, levonorgestrel intrauterine system and LoviOne in None (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Use of intrauterine contraception at 6 months post abortion. Planned start Oct 2024; status: authorised.
02
Drugs
avatrombopaglevonorgestrel intrauterine systemLoviOne
Beyond the preview
Go deeper on 2024-517082-16-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517082-16-01.